Parametric Portfolio Associates’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$300K Buy
+35,334
New +$326K ﹤0.01% 3281
2021
Q3
Sell
-10,621
Closed -$218K 3649
2021
Q2
$218K Buy
+10,621
New +$209K ﹤0.01% 3376

Other funds holding RCEL

Parametric Portfolio Associates's RCEL Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Avita Medical (RCEL) in Q1 2022: 35,334 shares worth $300K. The stake represents ﹤0.01% of the portfolio and ranks #3281 among its holdings. This is a return to the name: Parametric Portfolio Associates previously reported a position in RCEL as recently as Q2 2021.

Parametric Portfolio Associates first reported a position in RCEL in Q2 2021 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold RCEL as of Q1 2022.

  • Parametric Portfolio Associates held 35,334 shares of Avita Medical worth $300K as of Q1 2022.
  • Avita Medical was a new Parametric Portfolio Associates position in Q1 2022.
  • Avita Medical made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3281 holding.
  • Parametric Portfolio Associates first reported a position in Avita Medical in Q2 2021 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.